---
$id: https://graph.org.ai/products/commodity/51281620
$type: Product
source: UNSPSC
code: "51281620"
title: "Paromomycin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Paromomycin

**UNSPSC Code**: 51281620
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic with the molecular formula C23H45N5O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 61JJC8N5ZK, chemically known as streptamine, o-2,6-diamino-2,6-dideoxy-beta-l-idopyranosyl-(1-3)-o-beta-d-ribofuranosyl-(1-5)-o-(2-amino-2-deoxy-alpha-d-glucopyranosyl-(1-4))-2-deoxy- but generally known as paromomycin, which bears US NIH Compound Identifier 24176. European Medicines Agency schedules Paromomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09630MIG. The term PAROMOMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules paromomycin in its Anatomical Therapeutic Chemical (ATC) Classification. PAROMOMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule paromomycin under HS 29419000 and SITC 54139. As of Q4 2014, PAROMOMYCIN remains the US FDA Preferred Term for this commodity. Paromomycin bears US NLM identifiers UMLS ID C0030576 and NCI Concept Code C61878. SMILES: O(C1C(OC2OC(C(O)C(O)C2N)CO)C(N)CC(N)C1O)C1OC(C(OC2OC(C(O)C(O)C2N)CN)C1O)CO.

